Life Sciences
Sort by: Featured Most recent Most read Most commented
42 results total, viewing 11 - 20
GRRL Tech exposes nearly 500 to STEM industries
More than 470 girls from local high schools spent Thursday at the University of Rhode Island exploring STEM industries and career pathways during Tech Collective’s 12th annual GRRL Tech event. more
Nabsys lands $20M in Series D round
Nabsys Inc., a life sciences company focused on the creation of a single-molecule platform for genomic analysis, has closed a $20 million Series D financing round, the company announced Wednesday. more
Tech Collective announces R.I. Bioscience Award winners
Tech Collective, Rhode Island’s bioscience and IT industry association, has announced the six winners of its inaugural Rhode Island Bioscience Awards. more
| 2/25/13
‘Premier science comedian’ comedian to feature at Tech Collective awards
he Rhode Island Tech Collective announced last week that “science-centric” comedian Brian Malow is slated to perform at its inaugural Bioscience Awards celebration. more
UMass research spending surpasses $500M in FY2012
Research spending at the University of Massachusetts in fiscal year 2012 surpassed the $500 million mark for the third consecutive year, UMass President Robert L. Caret announced Wednesday. more
| 2/13/13
Covidien’s profits drop slightly in 1Q as sales rise 5%
Medical technology maker Covidien PLC reported first-quarter earnings of $493 million, or $1.03 per diluted share, a slight decrease from the $494 million, or $1.02 per diluted share, reported for the first-quarter of its fiscal 2012. more
| 1/25/13
Cumberland pharma firm moves to new office, lab in Mass.
Pharmaceutical developer Collegium Pharmaceutical Inc. has moved its operations out of Cumberland to more refined labs Canton, Mass., the company announced Thursday. more
R.I. medical tech industry building community
On Wednesday evening, Stephen Lane - chairman, chief venture officer and co-founder of Ximedica - played host to a diverse group of more than 40 members of Rhode Island's emerging med-tech community to discuss strategies to enhance connectivity and collaboration. more
Amgen reaches deal to use Bind’s technology to seek cancer drugs
Amgen Inc., one of the world’s biggest biotechnology companies, will spend as much as $180.5 million for the right to develop cancer drugs using nanotechnology from closely held Bind Biosciences. more
R.I. to receive $648K in Pfizer settlement
Rhode Island is set to receive $647,722 as part of a $42.9 million national settlement with drug maker Pfizer Inc. for the unlawful promotion of its drugs Zyvox and Lyrica. more
| 12/12/12
« Prev | 1 | 2 | 3 | 4 | 5 Next »
Calendar
PBN Hosted
Events

Celebrate RI's many exceptional women at PBN's Business Women Awards luncheon May 30th at the Providence Marriott. Reserve your seat today!
Advertisement
National
Local
Latest News